StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
1714.TW$9.81+3.26%
Fair $9.81+0.0%

1714.TW

Ho Tung Chemical Corp.

Basic Materials / ChemicalsTaiwan

$9.81

+0.31 (+3.26%)

Fairly Valued+0.0%Fair Value $9.81Fund rank 33/100 · Data gapFallback financials|
SA 47/C
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $1.1B · quality 64.3/100

Data gap 33/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 46/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

47/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is 4.0%, below the 5% threshold
Thesis & Journal · 1714.TWLocal privado en este navegador · Ho Tung Chemical Corp.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9.6B

P/E

19.6x

↑

EV/EBITDA

2.9x

↓

ROE

4.0%

↑

Gross Margin

10.4%

↓

Debt/Equity

0.26

↑
52-Week Range$10
$7$11

TradingView lightweight chart

1714.TW price, volumen y niveles de valoración

Último $9.810Periodo +81.2%
Fair value: $9.810

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+2.0%

FCF CAGR

—

FCF margin

3.4%

FCF / Net income

1.67x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $24.02B · net income $490.1M · FCF $816.9M

2022-FY → 2025-FY

Gross margin

10.4%+1.3% pts

Operating margin

5.2%+1.7% pts

Net margin

2.0%+0.4% pts

FCF margin

3.4%+4.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$24.02B$24.02B$20.62B$20.29B$22.64B
Net Income$490.1M$490.1M$415.5M$599.1M$370.2M
EBITDA$2.22B$2.22B$1.74B$1.71B$1.52B
EPS——0.410.590.37
Gross Margin10.4%10.4%9.3%9.4%9.1%
Operating Margin5.2%5.2%3.3%3.8%3.5%
Net Margin2.0%2.0%2.0%3.0%1.6%
Balance Sheet
Debt/Equity0.260.260.230.240.25
Current Ratio3.463.46———
Cash Flow
Free Cash Flow$816.9M$816.9M$1.13B$1.21B$-252.3M
Returns
ROE4.0%4.0%3.3%4.9%3.0%
Valuation
P/E19.6219.6219.2915.4223.30
EV/EBITDA2.902.902.613.264.14
P/B0.790.790.640.750.71
Growth & Yield
Revenue Growth16.5%16.5%1.6%-10.4%—
EPS Growth——-30.5%59.5%—
Dividend Yield2.1%2.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +23.4%

Total return

+23.4%

Start / end P/E

n/dx → n/dx

EPS bridge

0.41 → n/d

Residual

+21.3%

EPS growthn/d
Multiple reratingn/d
Dividend+2.1%
Residual / FX / buybacks / cross-term+21.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.